Filtered Listing Testing
BrightFocus Foundation, a leading nonprofit funder of global research on Alzheimer’s, macular degeneration, and glaucoma, today announced 93 new research grants, a $17.8 million commitment toward ending these age-related neurodegenerative diseases.
Helpful information to find Alzheimer's disease caregiver support groups
For a long time we’ve known that hypertension in midlife increases the risk of Alzheimer’s. Now BrightFocus-funded research is exploring that connection – with some surprising results that are relevant to COVID-19.
BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for science projects supported through its Macular Degeneration Research program.
BrightFocus Foundation, a nonprofit organization funding scientific research and promoting public awareness to end diseases of mind and sight, announced a special, free virtual presentation of the award-winning documentary LINDA RONSTADT: THE SOUND OF MY VOICE on June 4-10. The at-home movie night will feature an introduction from the film’s producer James Keach, and interviews with key scientists discussing their current research.
BrightFocus Foundation is partnering with the National Institute of Health’s (NIH’s) National Institute of Neurological Disorders and Stroke (NINDS) to fund an innovative research grant to develop retinal scans to identify early signs of vascular contributions to cognitive dementia (VCID), one of the leading causes of memory loss.
BrightFocus Foundation, a nonprofit organization funding scientific research and promoting public awareness to end Alzheimer’s, macular degeneration, and glaucoma, today announced Shawna Gottlieb and Tonya M. Matthews, PhD, as new members of its Board of Directors.
Learn how to decrease your risk of developing Alzheimer's disease, if statins increase or decrease Alzheimer's risk, new ideas to fight tau tangles, the BrightFocus-funded research of Nick Cochran, PhD, who is working to find out how an important gene for Alzheimer’s disease, called MAPT, is turned on in neurons, and more in the spring 2020 edition of Alzheimer's Disease Research Review.
Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
